Amber Therapeutics Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
56
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
12
Amber Therapeutics General Information
Description
Developer of neuromodulation therapies designed to treat mixed urinary incontinence in women. The company's platform offers a fully implantable device that stimulates and monitors the pudendal nerve using adaptive, sensor-driven technology, enabling personalized treatment that improves bladder control and quality of life.
Contact Information
Website
www.amber-tx.comCorporate Office
- Unit 1 Tech Foundry 2, Curie Avenue
- Harwell
- Didcot OX11 0QQ
- England, United Kingdom
Corporate Office
- Unit 1 Tech Foundry 2, Curie Avenue
- Harwell
- Didcot OX11 0QQ
- England, United Kingdom
Amber Therapeutics Timeline
Amber Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Accelerator/Incubator | 01-Jan-2026 | Completed | Generating Revenue | |||
| 4. Early Stage VC (Series A) | 09-Jun-2024 | Completed | Generating Revenue | |||
| 3. Seed Round | 18-Jun-2021 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | Completed | Startup | ||||
| 1. University Spin-Out | 18-Dec-2020 | Completed | Startup |
Amber Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Amber Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Amber Therapeutics Patents
Amber Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20260241181-A1 | Surgical techniques for implanting electrode leads | Pending | 20-Feb-2025 | ||
| US-20260245481-A1 | Neuromodulation surgical training system | Pending | 19-Feb-2025 | ||
| WO-2026087599-A1 | Adaptive neuromodulation system | Pending | 22-Oct-2024 | ||
| WO-2026087612-A1 | Time-dependent adaptive neuromodulation system | Pending | 22-Oct-2024 | ||
| GB-202314044-D0 | Adjustable skull mounted inductive charging alingment system | Inactive | 14-Sep-2023 |
Amber Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Amber Therapeutics Investors (12)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Tech Nation Group | Accelerator/Incubator | |||
| Fidelity | Corporation | Minority | ||
| F-Prime | Venture Capital | Minority | ||
| Intuitive Ventures | Corporate Venture Capital | Minority | ||
| Lightstone Ventures | Venture Capital | Minority |
Amber Therapeutics Acquisitions (1)
Amber Therapeutics’s most recent deal was a Merger/Acquisition with Bioinduction. The deal was made on 25-Jul-2023.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Bioinduction | 25-Jul-2023 | Merger/Acquisition | Therapeutic Devices |
Amber Therapeutics FAQs
-
When was Amber Therapeutics founded?
Amber Therapeutics was founded in 2020.
-
Where is Amber Therapeutics headquartered?
Amber Therapeutics is headquartered in Didcot, United Kingdom.
-
What is the size of Amber Therapeutics?
Amber Therapeutics has 56 total employees.
-
What industry is Amber Therapeutics in?
Amber Therapeutics’s primary industry is Drug Discovery.
-
Is Amber Therapeutics a private or public company?
Amber Therapeutics is a Private company.
-
What is Amber Therapeutics’s current revenue?
The current revenue for Amber Therapeutics is .
-
How much funding has Amber Therapeutics raised over time?
Amber Therapeutics has raised $101M.
-
Who are Amber Therapeutics’s investors?
Tech Nation Group, Fidelity, F-Prime, Intuitive Ventures, and Lightstone Ventures are 5 of 12 investors who have invested in Amber Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
